Investor Presentation

AI summary - Q1FY27 revenue at INR 69 Cr, up 5% YoY with same capacity - EBITDA steady at INR 15 Cr despite inflationary cost pressures - Operations expansion to start Q2FY27; captive solar power began end Q1FY27 - Debt-to-equity improved to 1.06x in FY26 from 3.50x in FY23 - Capex focused on capacity scale-up and solar power integration - Exports growing with presence in 21 countries and 47 products registered - SteriPort LVP capacity to expand with incremental revenue of INR 110-120 Cr/year - SVP capacity tripled, targeting inhalation and OTC portfolio growth - Solar plant 10.8 MW commissioned, expected annual savings INR 9 Cr - Management with 30+ years experience driving product and market expansion